Asthma Control in a Random Sample of New Zealand Adolescent Asthmatics

Asthma control, defined by asthma symptoms and lung function, and asthma medication use, was assessed in 123 adolescent asthmatics. Sputum eosinophilia (≥ 2.5% eosinophils) and bronchial hyperresponsiveness (BHR) to hypertonic saline were also measured to assess whether these additional objective parameters might aid in determining asthma control; 54.5% of subjects had adequately controlled asthma; 50.4% of all subjects reported inhaled corticosteroid use in the preceding 12 months; however, only 22.3% reported regular use. Although BHR and median eosinophil numbers were significantly higher in the inadequately controlled asthmatics, BHR and sputum eosinophilia had poor sensitivity for detecting inadequate asthma control.

[1]  Sean D Sullivan,et al.  Daily versus as-needed corticosteroids for mild persistent asthma. , 2005, The New England journal of medicine.

[2]  E. Gelfand,et al.  Do NHLBI lung function criteria apply to children? A cross‐sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999–2002 , 2005, Pediatric pulmonology.

[3]  C. Sorkness,et al.  Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. , 2004, American journal of respiratory and critical care medicine.

[4]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[5]  A. Butz,et al.  Physical activity in urban school-aged children with asthma. , 2004, Pediatrics.

[6]  S. Holt,et al.  Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001. , 2003, The New Zealand medical journal.

[7]  N. Zhong,et al.  Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. , 2003, The Journal of allergy and clinical immunology.

[8]  R. Djukanović,et al.  Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation , 2002, European Respiratory Journal.

[9]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[10]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[11]  A. Herxheimer,et al.  Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. , 2001, BMJ : British Medical Journal.

[12]  E. Bacci,et al.  Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  P. Gibson,et al.  Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. , 2000, The European respiratory journal.

[14]  K. Berhane,et al.  Sex-specific effects of asthma on pulmonary function in children. , 2000, American journal of respiratory and critical care medicine.

[15]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[16]  P. Newacheck,et al.  Prevalence, impact, and trends in childhood disability due to asthma. , 2000, Archives of pediatrics & adolescent medicine.

[17]  A. Cripps,et al.  Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. , 1998, American journal of respiratory and critical care medicine.

[18]  P. Gibson,et al.  Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. , 1998, The European respiratory journal.

[19]  W. Eder,et al.  Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children. , 1998, The European respiratory journal.

[20]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[21]  J. Riedler,et al.  Hypertonic saline challenge in an epidemiologic survey of asthma in children. , 1994, American journal of respiratory and critical care medicine.

[22]  D. Dockery,et al.  Gender- and race-specific effects of asthma and wheeze on level and growth of lung function in children in six U.S. cities. , 1994, American journal of respiratory and critical care medicine.

[23]  E. Mitchell,et al.  The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. , 1990, The American review of respiratory disease.

[24]  M. Spencer.  Asthma Insights and Reality in Asia Pacific Steering Committee , 2006 .

[25]  R. Beasley,et al.  The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[26]  Barrett T. Kitch,et al.  FEV(1) is associated with risk of asthma attacks in a pediatric population. , 2001, The Journal of allergy and clinical immunology.

[27]  J. Tonascia,et al.  Budesonide and nedocromil did not improve lung function in children with asthma The Childhood Asthma Management Program Research Group. Long›term effects of budesonide or nedocromil in children , 2001 .

[28]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.